Abstract:Recurrent aphthous stomatitis (RAS) represents the most common chronic oral diseases with the prevalence ranges from 5% to 25% for different populations. Its pathogenesis remains poorly understood, which limits the development of effective drugs and treatment methods. In this study, we conducted systemic bioinformatics analysis of gene expression profiles from the Gene Expression Omnibus (GEO) to identify potential drug targets for RAS. We firstly downloaded the gene microarray datasets with the accession number of GSE37265 from GEO and performed robust multi-array (RMA) normalization with affy R programming package. Secondly, differential expression genes (DEGs) in RAS samples compared with control samples were identified based on limma package. Enriched gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of DEGs were obtained through the Database for Annotation, Visualization and Integrated Discovery (DAVID). Finally, protein-protein interaction (PPI) network was constructed based on the combination of HPRD and BioGrid databases. What's more, we identified modules of PPI network through MCODE plugin of Cytoscape for the purpose of screening of valuable targets. As a result, 915 genes were found to be significantly differential expression in RAS samples and biological processes related to immune and inflammatory response were significantly enriched in those genes. Network and module analysis identified FBXO6, ITGA4, VCAM1 and etc as valuable therapeutic targets for RAS. Finally, FBXO6, ITGA4, and VCAM1 were further confirmed by real time RT-PCR and western blot. This study should be helpful for the research and treatment of RAS.

Expression of Bfgf in Recurrent Aphthous Ulcer and Its Biological Relevance

Expression of Bfgf in Recurrent Aphthous Ulcer and It's Significance

EGFR Protein and Gene Expression in Recurrent Aphthous Ulcer and Their Significance

[Proliferating Cell Nuclear Antigen Expression in Recurrent Aphthous Ulcer and Its Significance].

Frequencies of Abnormal Humoral and Cellular Immune Component Levels in Peripheral Blood of Patients with Recurrent Aphthous Ulceration

The Expressions of Basic Fibroblast Growth Factor in Oral Submucous Fibrosis

Establishment of Rats of Recurrent Aphthous Ulcer and EGF Expression in Seurm

The Study on the Expression of Bfgf in the Gingiva of Periodontal Diseases

Expression of Basic Fibroblast Growth Factor and Its Receptors in Morbid Human Corneas

Systemic bioinformatics analysis of recurrent aphthous stomatitis gene expression profiles.

Detection of the peripheral blood antigens and clinical value in recurrent aphthous ulcer: A cross-section study

Gene expression of platelet derived growth factors and their receptors in dermal chronic ulcers

Expression of u-PA and PAI-1 in oral submucous fibrosis

Expression and clinical significance of basic fibroblast growth factor in colorectal cancer tissues

Comparative study on the differential levels of humoral and cellular immunity indexes between refractory and general recurrent aphthous ulcer

Salivary microbiota and metabolic phenotype of patients with recurrent aphthous ulcers

Expression of Oncoproteins C-Fos and C-Jun in Hypertrophic Scars and Chronic Dermal Ulcers and Their Regulation of Basic Fibroblast Growth Factor.

The relationship between clinical characteristics and serum immunoglobulin and complement in recurrent ;aphthous ulcer

Serum Interleukin-6, Interleukin-17A, and Tumor Necrosis Factor-Alpha in Patients with Recurrent Aphthous Stomatitis.

Expression of Bfgf in the Human Gastric Adenocarcinoma and Clinical Significance

Effect of Recombinant Human Basic Fibroblast Growth Factor on Stomach Ulcers in Rats and Mice.